You are here: Industry Insights > AstraZeneca

News List

Catalent, AstraZeneca Ink Mfg. Pact for COVID-19 Vax contractpharma
June 16, 2020
Catalent preparing for large-scale commercial supply of the University of Oxford’s COVID-19 vaccine candidate AZD1222 starting August 2020.
Jacobs to Retrofit AstraZeneca’s Mfg. Facility for COVID-19 Vax contractpharma
June 16, 2020
Will upgrade an existing idle Fill Line in West Chester, OH to support formulation, vial filling, visual inspection and packaging of the COVID-19 vaccine.
AstraZeneca and Emergent Enter COVID-19 Vax Agreement contractpharma
June 15, 2020
Emergent to provide development and manufacturing services and secure large-scale manufacturing capacity through 2020 for AstraZeneca’s COVID-19 vax candidate.
Lynparza Recommended for Approval in EU by CHMP for BRCA-Mutated Metastatic Pancreatic Cancer americanpharmaceuticalreview
June 10, 2020
AstraZeneca and Merck announced Lynparza (olaparib) has been recommended for marketing authorization in the European Union (EU) for the 1st-line maintenance treatment of patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer.
AstraZeneca licences Covid-19 antibody candidates from VU pharmaceutical-technology
June 10, 2020
AstraZeneca has licensed six coronavirus-neutralising antibody candidates from Vanderbilt University (VU) in the US, with plans to advance two into clinical development to prevent and treat Covid-19.
Serum Institute to invest $100 million on potential COVID-19 vaccine expresspharma
June 10, 2020
It has partnered with AstraZeneca, a British company, to ensure equitable supply of the AZD1222 vaccine doses to India as well as low-and-middle-income countries.
AstraZeneca Takes Next Steps Towards Broad Access to Oxford’s COVID-19 Vaccine contractpharma
June 09, 2020
Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond.
AZ ramps up supply capacity for COVID-19 vaccine pharmatimes
June 08, 2020
AstraZeneca has sealed landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII) to broaden global access to the University of Oxford’s COVID-19 vaccine.
AstraZeneca signs $750m Covid-19 vaccine manufacturing deal pharmaceutical-technology
June 08, 2020
straZeneca has signed a $750m agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi the Vaccine Alliance for the production, procurement and distribution of 300 million doses of the University of Oxford’s Covid-19 vaccine.
AGC Biologics Acquires AstraZeneca Facility contractpharma
June 05, 2020
Site located in Boulder, CO adds commercial-scale manufacturing capacity for its biopharmaceutical CDMO business.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page